Is CJC-1295 Legal? Global Status Guide
Category: Growth Hormone · Tracked in 158 countries
29
Legal1
Research Only104
Grey Area20
Prescription4
BannedCan You Buy CJC-1295?
Whether you can buy CJC-1295 depends on your country. It is legal to purchase in 29 countries, including Jamaica, Dominican Republic, Bahamas, Trinidad and Tobago, Barbados, Cayman Islands, Aruba, Curacao, and 21 more. A prescription is required in 20 countries, including Australia, Germany, France, Netherlands, Sweden, Norway, Denmark, Spain, and 12 more. It falls into a legal grey area in 104 countries (United States, Canada, Mexico, US Virgin Islands, Saint Martin (French), Saint Barthelemy, Sint Maarten, Bonaire, and 96 more), where it may be available for research but not for human use. It is banned in 4 countries: Cuba, China, Singapore, Saudi Arabia.
Traveling with CJC-1295
Traveling internationally with CJC-1295 requires understanding local laws at your destination. Do not carry CJC-1295 into countries where it is banned (Cuba, China, Singapore, Saudi Arabia) — you could face serious legal consequences. In countries requiring a prescription (Australia, Germany, France, Netherlands, Sweden, Norway, Denmark, Spain, and 12 more), carry a valid prescription or doctor's letter. Always declare pharmaceutical products at customs and check the latest regulations before traveling.
Need to calculate your CJC-1295 dosage? Use the CJC-1295 reconstitution calculator on peptide.locker
CJC-1295 Legal Status by Country (158)
| Country | Status | Rx Required | Schedule | Detail |
|---|---|---|---|---|
| Anguilla | Legal | No | Not Scheduled | Not scheduled. General pharmaceutical law applies. |
| Antigua and Barbuda | Legal | No | Not Scheduled | Not scheduled. General drug act applies. |
| Aruba | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Bahamas | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Barbados | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Bosnia and Herzegovina | Legal | No | Not Registered | Non-EU. Not registered. GHRH analog. WADA banned. Research-label available. |
| British Virgin Islands | Legal | No | Not Scheduled | Not scheduled. General pharmaceutical law applies. |
| Cayman Islands | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Costa Rica | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Curacao | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Dominica | Legal | No | Not Scheduled | Not scheduled. General drug act applies. |
| Dominican Republic | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Georgia | Legal | No | Not Registered | Non-EU. Not registered. GHRH analog. WADA banned. Research-label available. Essentially unregulated. |
| Grenada | Legal | No | Not Scheduled | Not scheduled. General drug act applies. |
| Jamaica | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Montenegro | Legal | No | Not Registered | Non-EU. Not registered. GHRH analog. WADA banned. Research-label available. |
| Montserrat | Legal | No | Not Scheduled | Not scheduled. General pharmaceutical law applies. |
| North Macedonia | Legal | No | Not Registered | Non-EU. Not registered. GHRH analog. WADA banned. Research-label available. |
| Papua New Guinea | Legal | No | Not Scheduled | Not specifically regulated. No local market for GH secretagogues. No enforcement infrastructure for peptide imports. |
| Samoa | Legal | No | Not Scheduled | Not regulated. No local market or enforcement. |
| Serbia | Legal | No | Not Registered | Non-EU. Not registered as medicine. GHRH analog. WADA banned. Research-label available. Very low enforcement. |
| St Kitts and Nevis | Legal | No | Not Scheduled | Not scheduled. General drug act applies. |
| St Lucia | Legal | No | Not Scheduled | Not scheduled. General drug act applies. |
| St Vincent and the Grenadines | Legal | No | Not Scheduled | Not scheduled. General drug act applies. |
| Tonga | Legal | No | Not Scheduled | Not regulated. No local market or enforcement. |
| Trinidad and Tobago | Legal | No | Unregistered | Not specifically regulated. General drug act applies. |
| Turks and Caicos | Legal | No | Not Scheduled | Not scheduled. General pharmaceutical law applies. |
| Ukraine | Legal | No | Not Registered | Non-EU. Not registered. GHRH analog. WADA banned. Research-label available. Very low enforcement on research chemicals. |
| Vanuatu | Legal | No | Not Scheduled | Not regulated. No local market or enforcement. |
| United Kingdom | Research Only | No | Not Scheduled | Not a controlled substance. GHRPs not specifically scheduled in UK unlike Australia. Legal for research. |
| Algeria | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import restrictions effectively prevent access — must be marketed in origin + third country first. |
| Andorra | Grey Area | No | Not Scheduled | Not authorized by AMA. Unauthorized medicinal product. |
| Angola | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Minimal enforcement. |
| Argentina | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Bahrain | Grey Area | No | Unregistered | Not specifically regulated. |
| Bangladesh | Grey Area | No | Not Scheduled | Not registered with DGDA. No local market for GH peptides. |
| Belize | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Bolivia | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Bonaire | Grey Area | No | Not Scheduled | Not scheduled. Dutch medicines framework applies. |
| Botswana | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import without BoMRA permit illegal. |
| Brazil | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Brunei | Grey Area | No | Not Scheduled | Not registered. Cannot be legally imported or sold. No specific GH peptide regulation. |
| Bulgaria | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Cambodia | Grey Area | No | Unregistered | Available through local peptide suppliers. Not specifically restricted. |
| Cameroon | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import without authorization illegal. |
| Canada | Grey Area | No | Not Scheduled (CDSA) | Named in Health Canada seizure notices as unauthorized drug. No DIN. |
| Cape Verde | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Chile | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Colombia | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Croatia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Cyprus | Grey Area | No | Not Scheduled | No marketing authorization in EU. Unauthorized medicinal product under EU pharmaceutical law. |
| Democratic Republic of Congo | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Minimal enforcement. |
| Ecuador | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Egypt | Grey Area | No | Unregistered | Not specifically regulated. |
| El Salvador | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Estonia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Ethiopia | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Not a regulatory priority for EFDA. |
| Fiji | Grey Area | No | Unregistered | Not registered. Growth hormone peptides not specifically addressed. |
| French Guiana | Grey Area | No | Unauthorized Medicine | Not approved. French framework. |
| Ghana | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Guatemala | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Guyana | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Honduras | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Hong Kong | Grey Area | No | Unregistered | Not specifically regulated. |
| Hungary | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Iceland | Grey Area | No | WADA S2 (peptide hormones); unauthorized medicine | WADA S2 classified (GHRH analog). Postal import prohibited. Luggage import restricted to 30 days with doctor certificate. |
| India | Grey Area | No | Unregistered | Available from Indian pharmaceutical suppliers. |
| Indonesia | Grey Area | No | Unregistered | Not specifically regulated. |
| Iran | Grey Area | No | Not Scheduled | Not registered. No local market. Sanctions prevent import. |
| Iraq | Grey Area | No | Not Scheduled | Not registered. No specific regulation. Could enter through unregulated import. |
| Israel | Grey Area | No | Unregistered | Not specifically regulated. |
| Ivory Coast | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Japan | Grey Area | No | Unapproved Drug | Unapproved GH peptide. Strict PMDA framework. |
| Jordan | Grey Area | No | Unregistered | Not specifically regulated. |
| Kenya | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Kuwait | Grey Area | No | Unregistered | Not specifically regulated. |
| Laos | Grey Area | No | Unregistered | Not registered. Growth hormone peptides not specifically addressed. |
| Latvia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Lebanon | Grey Area | No | Not Scheduled | Not registered. No local market. Enforcement weakened by crisis. |
| Libya | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. No drug scheduling system. |
| Liechtenstein | Grey Area | No | Not Scheduled | No marketing authorization in EEA. Unauthorized medicinal product. |
| Lithuania | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Luxembourg | Grey Area | No | Not Scheduled | No marketing authorization in EU. Unauthorized medicinal product. |
| Madagascar | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Malawi | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Malaysia | Grey Area | No | Unregistered | Not specifically regulated. |
| Maldives | Grey Area | No | Unregistered | Not registered. Growth hormone peptides not specifically addressed. |
| Malta | Grey Area | No | Unauthorized Medicine | Not authorized. GHRH analog not approved by EMA. Cannot be legally sold or imported for human use. |
| Mauritius | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Mexico | Grey Area | No | Unregistered | Available at peptide clinics (Renovo, ResCore, Holistic Bio Spa). Commonly paired with Ipamorelin. |
| Monaco | Grey Area | No | Not Scheduled | No marketing authorization. Unauthorized medicinal product under French/EU pharmaceutical law. |
| Morocco | Grey Area | No | Unregistered | No AMM. Not specifically regulated. No domestic market for research peptides. |
| Mozambique | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| Myanmar | Grey Area | No | Unregistered | Available through drug shops if imported. No enforcement of restrictions. |
| Namibia | Grey Area | No | Unregistered | Not registered. No domestic market. |
| Nepal | Grey Area | No | Unregistered | Not registered. Hormones Category KHA but growth hormone peptides not specifically listed. |
| Nicaragua | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Nigeria | Grey Area | No | Unregistered | Not specifically regulated. Not NAFDAC registered. No domestic market. |
| Oman | Grey Area | No | Unregistered | Not specifically regulated. |
| Pakistan | Grey Area | No | Not Scheduled | Not registered with DRAP. No local market for GH peptides. |
| Panama | Grey Area | No | Unregistered | Available at anti-aging/wellness clinics. |
| Paraguay | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Peru | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Philippines | Grey Area | No | Unregistered | Not specifically regulated. |
| Qatar | Grey Area | No | Unregistered | Not specifically regulated. |
| Romania | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. Low enforcement. |
| Russia | Grey Area | No | Unregistered | Not officially registered but available. |
| Rwanda | Grey Area | No | Unregistered | Not registered. No domestic market. |
| Saba | Grey Area | No | Not Scheduled | Not scheduled. Dutch medicines framework applies. |
| Saint Barthelemy | Grey Area | No | Unauthorized Medicine | Not approved. French pharma law applies. |
| Saint Martin (French) | Grey Area | No | Unauthorized Medicine | Not approved. French pharma law applies. |
| Senegal | Grey Area | No | Unregistered | Not registered. No domestic market. |
| Seychelles | Grey Area | No | Unregistered | Not registered. Growth hormone peptides not specifically addressed. |
| Sint Eustatius | Grey Area | No | Not Scheduled | Not scheduled. Dutch medicines framework applies. |
| Sint Maarten | Grey Area | No | Not Scheduled | Not scheduled. Dutch medicines framework applies. |
| Slovakia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Slovenia | Grey Area | No | Not Scheduled / Unauthorized | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| South Africa | Grey Area | No | Unregulated | Not specifically scheduled by SAHPRA. Growth hormone releasing peptides not individually listed in SA schedules (unlike Australia). Available from SA research peptide vendors. Clinics offer CJC-1295/Ipamorelin protocols. Note: actual HGH (somatotropin) IS Schedule 5. |
| South Korea | Grey Area | No | Unregistered | Not specifically regulated. |
| Sri Lanka | Grey Area | No | Unregistered | Not registered. Growth hormone peptides not approved by reference authorities. |
| Suriname | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Taiwan | Grey Area | No | Unregistered | Not specifically regulated. |
| Tanzania | Grey Area | No | Unregistered | Not TMDA registered. Import would require permit. |
| Thailand | Grey Area | No | Unregistered | Available at anti-aging clinics in Bangkok, Phuket, Chiang Mai. |
| Tunisia | Grey Area | No | Unregistered | No MA. Not specifically regulated. No domestic market. |
| Turkey | Grey Area | No | Unregistered | Not specifically regulated. |
| Uganda | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. |
| United States | Grey Area | No | Not Scheduled | Removed from Category 2 prohibited list Sept 2024 after nominators withdrew. NOT cleared for compounding — under PCAC review. Cannot be legally compounded pending review outcome. |
| Uruguay | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| US Virgin Islands | Grey Area | No | Not Scheduled | Same as US. Removed from Category 2 Sept 2024. Under PCAC review. |
| Venezuela | Grey Area | No | Unregistered | Not specifically regulated. General pharma law applies. |
| Vietnam | Grey Area | No | Unregistered | Not specifically regulated. |
| Zambia | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import without ZAMRA authorization illegal. |
| Zimbabwe | Grey Area | No | Unregistered | Not specifically regulated. No domestic market. Import without MCAZ authorization illegal. |
| Australia | Prescription | Yes | Schedule 4 + Appendix D Item 5 | Individually named in Schedule 4 + Appendix D since 1 June 2015. Captured by both individual entry AND class entry (GHRHs). |
| Austria | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Belgium | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Czech Republic | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Denmark | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Finland | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| France | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Germany | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Greece | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Ireland | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Italy | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Netherlands | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| New Zealand | Prescription | Yes | Unapproved (Rx Required) | Prescription medicine. Not Medsafe approved. |
| Norway | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Poland | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Portugal | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Spain | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Sweden | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| Switzerland | Prescription | Yes | Unauthorized Medicine | No EMA authorization. GHRH analog. WADA banned. Research-label available. |
| United Arab Emirates | Prescription | Yes | Clinic Prescribed | Available at anti-aging clinics. Prescription required. |
| China | Banned | No | Unapproved Drug | Unauthorized. No consumer access. |
| Cuba | Banned | No | State Controlled | State pharmaceutical monopoly via CECMED/BioCubaFarma. No private purchase/import permitted. |
| Saudi Arabia | Banned | No | Unauthorized | Unauthorized. Do not import. |
| Singapore | Banned | No | Unapproved Health Product | Unapproved. Do not import. |
Data is researcher-verified but not legal advice. Regulations change frequently. Always verify with local authorities before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.